Bicoll and the European Molecular Biology Laboratory (EMBL) announce results of their joint research project on the identification of aurora kinase inhibitors
Munich (Germany), Heidelberg (Germany) – June 22, 2010 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry to identify novel small molecules for drug discovery and related innovative fields and EMBL, the renowned international and …